2. Academic Validation
  3. Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor

Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor

  • J Med Chem. 1996 Apr 26;39(9):1767-70. doi: 10.1021/jm960054c.
D C Dean 1,  R P Nargund,  S S Pong,  L Y Chaung,  P Griffin,  D G Melillo,  R L Ellsworth,  L H Van der Ploeg,  A A Patchett,  R G Smith
Affiliations

Affiliation

  • 1 Department of Drug Metabolism, Merck Research Laboratories, Merck & Co., Rahway, New Jersey 07065, USA.
PMID: 8627599 DOI: 10.1021/jm960054c
Figures